Patarajarin Akarapipad

Ms. Patarajarin Akarapipad

Johns Hopkins University, Baltimore, Maryland, USA
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2018 in Scientific Reports
Verified
Journal Article
Open access
KKKattika Kaarj
Kattika Kaarj
Patarajarin AkarapipadPatarajarin Akarapipad
Patarajarin Akarapipad
Jeong-Yeol YoonJeong-Yeol Yoon
Jeong-Yeol Yoon
The recent Zika virus (ZIKV) outbreak has prompted the need for field-ready diagnostics that are rapid, easy-to-use, handheld, and disposable while providing extreme sensitivity and specificity. To meet this demand, we developed a wax-printed paper microfluidic chip utilizing reverse transcription loop-mediated isothermal amplification (RT-LAMP). The developed simple and sensitive ZIKV assay was demonstrated using undiluted tap water, human urine, and diluted (10%) human blood plasma. Paper type, pore size, and channel dimension of various paper microfluidic chips were investigated and optimized to ensure proper filtration of direct-use biological samples (tap water, urine, and plasma) during capillary action-driven flow. Once ZIKV RNA has flowed and reached to a detection area of the paper microfluidic chip, it was excised for the addition of an RT-LAMP mixture with a pH indicator, then placed on a hot plate at 68 °C. Visible color changes from successful amplification were observed in 15 minutes and quantified by smartphone imaging. The limit of detection was as low as 1 copy/μL. The developed platform can also be used for identifying other flaviviruses, such as Chikungunya virus (CHIKV) and Dengue virus (DENV), and potentially other quickly transmitted virus pathogens, towards field-based diagnostics.

17 March 2022 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
Patarajarin AkarapipadPatarajarin Akarapipad
Patarajarin Akarapipad
KKKattika Kaarj
Kattika Kaarj
LBLane E. Breshears
Lane E. Breshears
KSKatelyn Sosnowski
Katelyn Sosnowski
JBJacob Baker
Jacob Baker
Jeong-Yeol YoonJeong-Yeol Yoon
Jeong-Yeol Yoon

24 December 2021 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
SKSangsik Kim
Sangsik Kim
Patarajarin AkarapipadPatarajarin Akarapipad
Patarajarin Akarapipad
BNBrandon T. Nguyen
Brandon T. Nguyen
LBLane E. Breshears
Lane E. Breshears
KSKatelyn Sosnowski
Katelyn Sosnowski
Jeong-Yeol YoonJeong-Yeol Yoon
Jeong-Yeol Yoon

7 April 2020 in MEDICAL DEVICES & SENSORS
Verified
Journal Article
Closed access
PDF file
KSKatelyn Sosnowski
Katelyn Sosnowski
Patarajarin AkarapipadPatarajarin Akarapipad
Patarajarin Akarapipad
Jeong-Yeol YoonJeong-Yeol Yoon
Jeong-Yeol Yoon

7 November 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
Patarajarin AkarapipadPatarajarin Akarapipad
Patarajarin Akarapipad
EBElizabeth M.W. Bertelson
Elizabeth M.W. Bertelson
APAlexander Pessell
Alexander Pessell
TWTza-Huei Wang
Tza-Huei Wang
KHKuangwen Hsieh
Kuangwen Hsieh
The COVID-19 pandemic caused by SARS-CoV-2 has drawn attention to the need for fast and accurate diagnostic testing. Concerns from emerging SARS-CoV-2 variants and other circulating respiratory viral pathogens further underscore the importance of expanding diagnostic testing to multiplex detection, as single-plex diagnostic testing may fail to detect emerging variants and other viruses, while sequencing can be too slow and too expensive as a diagnostic tool. As a result, there have been significant advances in multiplex nucleic-acid-based virus diagnostic testing, creating a need for a timely review. This review first introduces frequent nucleic acid targets for multiplex virus diagnostic tests, then proceeds to a comprehensive and up-to-date overview of multiplex assays that incorporate various detection reactions and readout modalities. The performances, advantages, and disadvantages of these assays are discussed, followed by highlights of platforms that are amenable for point-of-care use. Finally, this review points out the remaining technical challenges and shares perspectives on future research and development. By examining the state of the art and synthesizing existing development in multiplex nucleic acid diagnostic tests, this review can provide a useful resource for facilitating future research and ultimately combating COVID-19.

20 June 2024 in Sensors and Actuators Reports
Verified
Journal Article
Open access
HNHoan T. Ngo
Hoan T. Ngo
Patarajarin AkarapipadPatarajarin Akarapipad
Patarajarin Akarapipad
PLPei-Wei Lee
Pei-Wei Lee
JPJoon Soo Park
Joon Soo Park
FCFan-En Chen
Fan-En Chen
KHKuangwen Hsieh
Kuangwen Hsieh
For the 29.8 million people in the world living with HIV/AIDS and receiving antiretroviral therapy, it is crucial to monitor their HIV viral loads. To this end, rapid and portable diagnostic tools that can quantify HIV RNA are critically needed. We report herein a rapid and quantitative digital CRISPR-assisted HIV RNA detection assay that has been implemented within a portable smartphone-based device as a potential solution. Specifically, we first developed a fluorescence-based reverse transcription recombinase polymerase amplification (RT-RPA)-CRISPR assay that can efficiently detect HIV RNA at 42 °C. We then implemented this assay within a commercial stamp-sized digital chip, where RNA molecules were quantified as strongly fluorescent digital reaction wells. The isothermal reaction condition and the strong fluorescence in the digital chip simplified the design of thermal and optical modules, allowing us to engineer a palm-size device measuring 70 × 115 × 80 mm and weighing less than 0.6 kg. We also capitalized the smartphone by developing a custom app to control the device, perform the digital assay, and capture fluorescence images throughout the assay using the smartphone's camera. Moreover, we trained and verified a deep learning-based algorithm for analyzing fluorescence images and identifying positive digital reaction wells with high accuracy. Using our smartphone-enabled digital CRISPR device, we successfully detected as low as 75 copies of HIV RNA in just 15 min, showing its potential toward monitoring of HIV viral loads and aiding the global effort to combat the HIV/AIDS epidemic.